3-Methylcyclohexane-1,2-dione
Common Name: |
3-Methylcyclohexane-1,2-dione |
IUPAC Name: |
3-methylcyclohexane-1,2-dione |
Molecular Formula: |
C10H12O4 |
SMILES: |
CC1CCCC(=O)C1=O |
Inchi: |
1S/C7H10O2/c1-5-3-2-4-6(8)7(5)9/h5H,2-4H2,1H3 |
Inchi Key: |
JDXJKLGWPNXSHL-UHFFFAOYSA-N |
Cas No: |
3008-43-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
196.20 |
Mass (g/mol) |
126.068 |
Molar Refractivity |
51.06 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
56.51 |
Hetero Atoms |
2 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
57.00 to 63.00 |
Boiling Point (°C@760.00mm Hg) |
69.00 to 72.00 @ 1.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.321 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.40 |
LogP |
0.945 |
iLOGP |
2.34 |
XLOGP3 |
1.50 |
WLOGP |
1.51 |
MLOGP |
0.34 |
ESOL Log S |
-2.12 |
ESOL Solubility (mg/ml) |
1.49 |
ESOL Solubility (mol/l) |
0.008 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.29 |
Ali Solubility (mg/ml) |
1 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.84 |
Silicos-IT Solubility (mg/ml) |
0.28 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.43 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.764 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.073 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |